(Q37484614)

English

Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines

scientific article published on 25 April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

1 reference

Europe PubMed Central

Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

4

object named as

Ron Dagan

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

author name string

Gail L Rodgers

1

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Adriano Arguedas

2

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Robert Cohen

3

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

language of work or name

0 references

publication date

25 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

3802-3810

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Diagnosis and management of acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

National trends in emergency department antibiotic prescribing for children with acute otitis media, 1996 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Bacteriology of acute otitis media: A new perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conju

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Pneumococcal serotypes from acute otitis media in rural Kentucky.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Impact of the pneumococcal conjugate vaccine on otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Population-based impact of pneumococcal conjugate vaccine in young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Changes in frequency and pathogens causing acute otitis media in 1995-2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Otitis media in young Aboriginal children from remote communities in Northern and Central Australia: a cross-sectional survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

The clinical course of acute otitis media in high-risk Australian Aboriginal children: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Otitis media in Australian Aboriginal children: an overview.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

A systematic review of clinical research addressing the prevalence, aetiology, diagnosis, prognosis and therapy of otitis media in Australian Aboriginal children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Serotypes in pneumococcal disease. A ten year study in Australia 1970 through 1979

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Pneumococci responsible for invasive disease and discharging ears in children in Sydney, Australia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Molecular characterisation of pneumococcal serotype 16F: Established predominant carriage and otitis media serotype in the 7vPCV era.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

[Bacterial epidemiological study of acute otitis media in children observed at home in the Nord Pas-de-Calais region].

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Pneumococcal acute otitis media in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Association of clinical signs and symptoms with pneumococcal acute otitis media by serotype--implications for vaccine effect

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Epidemiology and antimicrobial resistance of Streptococcus pneumoniae strains isolated in Ile de France area during 2001

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive infections and acute otitis media in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Serotyping and antibiotic resistance of Streptococcus pneumoniae isolated from pediatric infections in central Greece.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Serotype distribution of Streptococcus pneumoniae in north-western Greece and implications for a vaccination programme

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Antibiotic susceptibility of acute otitis media pathogens in otitis-prone Belgian children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Multiple antimicrobial resistance of pneumococci in children with otitis media, bacteremia, and meningitis in Slovakia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Antimicrobial resistance of Streptococcus pneumoniae in Finland, 1987-1990.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Microbiology of otitis media in Costa Rican children, 1999 through 2001

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Microbiology of acute otitis media in Costa Rican children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Bacterial and viral etiology of acute otitis media in Chilean children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Penicillin resistance is not extrapolable to amoxicillin resistance in Streptococcus pneumoniae isolated from middle ear fluid in children with acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Middle ear fluid Streptococcus pneumoniae serotype distribution in Costa Rican children with otitis media.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Multinational study of pneumococcal serotypes causing acute otitis media in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Acute otitis media in Brazilian children: analysis of microbiology and antimicrobial susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

[Epidemiological survey of pneumococcus serotypes in pediatric patients with acute suppurative otitis media]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Bacterial aetiology of non-resolving otitis media in South African children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

An international serotype 3 clone causing pediatric noninvasive infections in Israel, Costa Rica, and Lithuania

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

based on heuristic

inferred from DOI database lookup

Streptococcus pneumoniae in children in Spain: 1990-1999.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

based on heuristic

inferred from DOI database lookup

Microbiologic efficacy of antibacterial drugs for acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.021

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.04.021

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37484614&oldid=2175820039"